Universe · entity
NEA Management Company, LLC
Institutional manager (13F) · CIK 1512848
13F holdings · as of 2026-03-31 · top 26 · reported portfolio $1.8B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | Arcellx, Inc. | $350M | 3,045,262 |
| 2 | Celcuity Inc. | $261M | 2,285,561 |
| 3 | Spyglass Pharma, Inc. | $192M | 7,392,301 |
| 4 | Trevi Therapeutics, Inc. | $158M | 13,222,228 |
| 5 | Savara, Inc. | $134M | 24,471,264 |
| 6 | Monte Rosa Therapeutics, Inc. | $127M | 7,692,298 |
| 7 | MBX Biosciences, Inc. | $108M | 3,614,486 |
| 8 | Zenas BioPharma, Inc. | $79M | 4,023,219 |
| 9 | Coursera, Inc. | $75M | 12,867,769 |
| 10 | Aurinia Pharmaceuticals, Inc. | $59M | 3,969,834 |
| 11 | ORIC Pharmaceuticals, Inc. | $52M | 4,118,621 |
| 12 | CRISPR Therapeutics AG | $50M | 1,058,570 |
| 13 | Phathom Pharmaceuticals, Inc. | $22M | 1,960,169 |
| 14 | CVRx, Inc. | $19M | 2,026,083 |
| 15 | Korro Bio, Inc. | $15M | 1,297,893 |
| 16 | X4 Pharmaceuticals, Inc. | $13M | 3,233,743 |
| 17 | Champions Oncology, Inc. | $10M | 1,713,720 |
| 18 | Black Diamond Therapeutics, Inc. | $9M | 4,448,757 |
| 19 | Inventiva SA | $8M | 1,462,586 |
| 20 | Nkarta, Inc. | $8M | 3,568,781 |
| 21 | LeonaBio, Inc. | $5M | 464,398 |
| 22 | Senti Biosciences, Inc. | $3M | 3,775,615 |
| 23 | Marker Therapeutics, Inc. | $2M | 1,625,678 |
| 24 | OnKure Therapeutics, Inc. | $2M | 478,548 |
| 25 | Gossamer Bio, Inc. | $329k | 1,000,000 |
| 26 | ImageneBio, Inc. | $250k | 50,005 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.